The recent ruling in Texas that effectively bans the use of mifepristone for abortions after seven weeks of pregnancy is a deeply concerning development for patient rights and access to care. Mifepristone, also known as RU-486, is a safe and effective medication used in combination with misoprostol to induce an abortion in the first trimester of pregnancy. The medication is prescribed by healthcare providers and can be taken at home, which makes it a particularly important option for patients in rural or remote areas without easy access to abortion clinics. The Texas law, which was upheld by the Supreme Court, imposes severe restrictions on the use of mifepristone, including requiring that patients receive the medication in person at a clinic, rather than through telemedicine, and requiring that the medication be administered in accordance with outdated protocols that are not in line with current medical practice. These restrictions make it more difficult and expensive for patients to ...